SQSTM1 and intrahepatic cholangiocarcinoma: In the last decades, increasing evidence demonstrated the accumulation of p62 in various tumors, including hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).2, 3, 4, 6